These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
668 related articles for article (PubMed ID: 17394230)
1. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE; Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230 [TBL] [Abstract][Full Text] [Related]
2. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study. Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358 [TBL] [Abstract][Full Text] [Related]
4. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142 [TBL] [Abstract][Full Text] [Related]
5. In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis. Sakellariou G; Scirè CA; Verstappen SM; Montecucco C; Caporali R Ann Rheum Dis; 2013 Feb; 72(2):245-9. PubMed ID: 23060009 [TBL] [Abstract][Full Text] [Related]
6. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Smolen JS; Aletaha D Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103 [TBL] [Abstract][Full Text] [Related]
8. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints. Kaneko Y; Kondo H; Takeuchi T J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077 [TBL] [Abstract][Full Text] [Related]
9. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab. Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431 [TBL] [Abstract][Full Text] [Related]
10. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151 [TBL] [Abstract][Full Text] [Related]
11. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy. Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371 [TBL] [Abstract][Full Text] [Related]
12. Assessing remission in clinical practice. Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506 [TBL] [Abstract][Full Text] [Related]
13. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185 [TBL] [Abstract][Full Text] [Related]
14. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis. Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881 [TBL] [Abstract][Full Text] [Related]
15. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points. Mack ME; Hsia E; Aletaha D Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724 [TBL] [Abstract][Full Text] [Related]
16. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867 [TBL] [Abstract][Full Text] [Related]
17. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort. Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821 [TBL] [Abstract][Full Text] [Related]
18. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234 [TBL] [Abstract][Full Text] [Related]
19. Minimal disease activity for rheumatoid arthritis: a preliminary definition. Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362 [TBL] [Abstract][Full Text] [Related]
20. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis. Shidara K; Nakajima A; Inoue E; Hoshi D; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H J Rheumatol; 2017 Feb; 44(2):147-153. PubMed ID: 27909083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]